Accurate Display of Postpartum Hemorrhage Using Triton (ADOPT)

Completed

Conditions studied: Post-partum Hemorrhage (PPH)

In brief

A comparison of reported estimated blood loss with quantified blood loss in all patients whose medical records indicate Triton was used during their vaginal delivery.

Key facts

Study ID

NCT02981758

Run by

Hackensack Meridian Health

People needed

300

Starts

2016-07-01

Expected to finish

2019-09-01

Last updated by the study team

2020-02-11

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• All women who delivered (vaginally) at HackensackUMC who had blood loss and measured quantitatively by Triton and qualitatively (i.e., EBL) by obstetrician.
• All women who had vaginal deliveries between 2010 and 2015 at HackensackUMC who had a procedure code indicative of transfusion (99.0x) or received a diagnosis suggestive of peripartum hemorrhage (e.g. diagnosis x code 666.xx, 641.x, 645.x, 646.x 674.x).

You may not qualify if…

• Women who received transfusions unrelated directly to pregnancy (e.g. renal disease, anemia of pregnancy, genetic or viral conditions causing anemia).

Where it is running

• Hackensack University Medical Center — Hackensack, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.